Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells.
about
Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cellsA paradigm shift: Cancer therapy with peptide-based B-cell epitopes and peptide immunotherapeutics targeting multiple solid tumor types: Emerging concepts and validation of combination immunotherapyAntagonists of retinoic acid receptors (RARs) are potent growth inhibitors of prostate carcinoma cellsMicrornas in prostate cancer: an overview.Identification of differentially expressed genes associated with androgen-independent growth of prostate cancer.Variations of proline-rich kinase Pyk2 expression correlate with prostate cancer progression.Minireview: the molecular and genomic basis for prostate cancer health disparitiesSynergistic effects of combined platelet-activating factor receptor and epidermal growth factor receptor targeting in ovarian cancer cellsStem cell differentiation within the human prostate epithelium: implications for prostate carcinogenesis.Inhibition of EGFR-AKT axis results in the suppression of ovarian tumors in vitro and in preclinical mouse model.Difference in protein expression profile and chemotherapy drugs response of different progression stages of LNCaP sublines and other human prostate cancer cellsNew advances on prostate carcinogenesis and therapies: involvement of EGF-EGFR transduction system.ErbB receptors: possible therapeutic targets in prostate cancer?Epidermal growth factor, neurotrophins and the metastatic cascade in prostate cancer.Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer.Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence.The role of stress proteins in prostate cancer.Molecular mechanisms involving prostate cancer racial disparity.Promising tumor-associated antigens for future prostate cancer therapy.Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth.Identification of the zinc finger 216 (ZNF216) in human carcinoma cells: a potential regulator of EGFR activity.Gαs protein expression is an independent predictor of recurrence in prostate cancerEpidermal growth factor increases LRF/Pokemon expression in human prostate cancer cells.The role of microRNAs in prostate cancer progression.High-Throughput Screen for Inhibitors of Androgen Receptor-RUNX2 Transcriptional Regulation in Prostate Cancer.Prostate Cancer in African American Men: The Effect of Androgens and microRNAs on Epidermal Growth Factor Signaling.Proteomics analyses of prostate cancer cells reveal cellular pathways associated with androgen resistance.Role of proprotein convertases in prostate cancer progression.Prostate cancer cells and bone stromal cells mutually interact with each other through bone morphogenetic protein-mediated signals.Loss of EGFR induced autophagy sensitizes hormone refractory prostate cancer cells to adriamycin.Androgen regulates ADAMTS15 gene expression in prostate cancer cells.Exogenous p27KIP1 expression induces anti-tumour effects and inhibits the EGFR/PI3K/Akt signalling pathway in PC3 cells.Suppression of ErbB-2 in androgen-independent human prostate cancer cells enhances cytotoxic effect by gemcitabine in an androgen-reduced environment.Epidermal Growth Factor Receptor Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated with Docetaxel Chemotherapy.Prostate cancer cells generated during intermittent androgen ablation acquire a growth advantage and exhibit changes in epidermal growth factor receptor expression.Inhibition of cell signaling by the combi-nitrosourea FD137 in the androgen independent DU145 prostate cancer cell line.EPN: a novel epithelial cell line derived from human prostate tissue.Effect of an EGF-R selective tyrosine kinase inhibitor and an anti-androgen on LNCaP cells: identification of divergent growth regulatory pathways.Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways.Selective uptake of epidermal growth factor-conjugated gold nanoparticle (EGF-GNP) facilitates non-thermal plasma (NTP)-mediated cell death
P2860
Q22254244-09D9985D-A941-46D5-82AD-BBCA824A62E1Q26824462-78A008A7-97D3-47F8-8C87-F99B12D1F948Q28345397-68F8F3AD-9D95-4E1E-92DF-E64D07F38995Q30234658-D1EDF9C9-44B6-4CE9-8A68-9BE590F10FAAQ30835299-23A07B33-F3DB-4326-B253-7A5BCECE61EBQ32005910-E057A999-A363-435F-90B2-4354230E2B93Q33633160-CDFE1337-8065-4CDA-8739-FEDC47980284Q33637787-665A45C6-A349-48BC-AF35-C0B422C670FAQ34394076-C847B3A1-DB15-4686-B276-423B81A88530Q34405324-D87DFC46-1BB1-404F-A9DB-577119A378FFQ35070404-8959B739-0B24-4325-A1D0-C8D8C084624BQ35149046-7C1818A8-73DD-4765-BAF5-B8AE994CCAA7Q35591109-202F7683-FC27-48DF-AD64-9060EB0A0DAAQ35848658-313991A0-F4B7-417F-9C8B-6A4AD1719EA5Q36072084-97E697DF-F37A-4977-98E1-768CF68D5AF8Q36696600-10C1C3B6-22BF-4D0B-8785-6427815E36ACQ37223453-7F7A8D75-212B-4331-A325-51EA6D83BA02Q37418937-2778621C-5049-4D5F-9A98-C9BE706B3B40Q37523602-6169A756-71A3-4A1A-8ADE-4C2905343B64Q37627154-027A78F0-06AD-4B0C-A453-E6ADBF468F19Q37688876-3305ADCB-DCC8-4274-BBA8-D8A17C8DB820Q37706058-951FFEA1-7C42-42E4-BAFF-1F3E144DF966Q38504519-00288B6E-A508-40CF-A4D9-080827B293BAQ38712604-BC298031-A44D-44D8-82AB-55DE54BDA78FQ38750494-5F6385A7-E9BA-4A28-8B10-F61838360402Q38905604-8EFB6222-A168-4F08-96FC-0AE36A87191CQ39002801-568E51F4-3E67-4494-8EDE-40F30E17943AQ39229279-C53710F9-C6AA-4E62-BC1A-712D8E9DA5EFQ39359077-2C7DA510-5590-41A3-B7AA-1378A591AF71Q39527913-5DA3B7E1-C52C-4628-B86A-C7BA2B45499AQ39686773-07769B9A-EDDC-47BD-899B-24B5C47D236CQ39802754-9A070C75-EA73-4DB1-8A00-DB2CC7516676Q39847370-01C207A5-C6A5-4341-A188-B2FF99A8AD4EQ39934173-D44C0B40-F038-47EC-B31F-7BDF084D7483Q40569962-E22D372D-5C6F-4891-8B1C-745C454A359EQ40584070-723CA532-F3E9-4056-8892-53CF4D192757Q40730255-25F3C48B-03B1-4DED-B42F-1FD3CFD8C183Q40781423-AF9B7D63-38A8-46FE-9A03-14F983AD3D46Q40869861-6B07A9EE-FA7B-418E-AA3B-4CD1784D25DCQ41476953-1B446B5A-E6DC-4FD2-92A2-AEAAE3742DFA
P2860
Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Epidermal growth factor recept ...... man prostatic carcinoma cells.
@ast
Epidermal growth factor recept ...... man prostatic carcinoma cells.
@en
type
label
Epidermal growth factor recept ...... man prostatic carcinoma cells.
@ast
Epidermal growth factor recept ...... man prostatic carcinoma cells.
@en
prefLabel
Epidermal growth factor recept ...... man prostatic carcinoma cells.
@ast
Epidermal growth factor recept ...... man prostatic carcinoma cells.
@en
P2093
P2860
P356
P1476
Epidermal growth factor recept ...... man prostatic carcinoma cells.
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1998.142
P407
P577
1998-03-01T00:00:00Z